Aldeyra The (ALDX) Metrics: History & Chart

Aldeyra The(ALDX)

Biotechnology · Lexington, MA

$0.88-0.05 (-4.94%)

Delayed quote: Oct 6, 2026, 2:20 PM EDT

About Aldeyra The

Aldeyra Therapeutics, Inc., a biotechnology company, discovers and develops therapies designed to treat immune-mediated diseases. Its lead product candidate is reproxalap, a reactive aldehyde species (RASP) modulator, which is in Phase III clinical trial for the treatment of dry eye disease and allergic conjunctivitis; and ADX-2191, a dihydrofolate reductase inhibitor for the treatment of primary vitreoretinal lymphoma and retinitis pigmentosa. The company also develops ADX-629, an orally administered RASP modulator that is in Phase 2 clinical trials for the treatment of COVID-19, atopic asthma, psoriasis, and alcohol intoxication. In addition, it develops preclinical RASP platforms, including ADX 248, ADX 246, and other novel RASP modulators for the treatment of various diseases associated with RASP. The company was formerly known as Aldexa Therapeutics, Inc. and changed its name to Aldeyra Therapeutics, Inc. in March 2014. Aldeyra Therapeutics, Inc. was incorporated in 2004 and is based in Lexington, Massachusetts.

Lexington, MA

6 employees

www.aldeyra.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Todd C. Brady

View full financials

Third-Party DCF Estimate (FMP)	$0.91
Price Gap vs Third-Party Estimate	-1.99%

7D Total Return	-20.37%
30D Total Return	-37.59%
YTD Total Return	-82.17%
1Y Total Return	-83.91%
3Y Total Return	-84.13%
5Y Total Return	-89.70%
10Y Total Return	-87.70%
15Y Total Return	N/A
20Y Total Return	N/A

2026	-82.17%
2025	+3.81%
2024	+42.17%
2023	-49.57%
2022	+74.00%
2021	-41.69%
2020

CAGR TTM	-83.77%
CAGR 3Y	-45.85%
CAGR 5Y	-36.54%
CAGR 10Y	-18.91%
CAGR 15Y	N/A
CAGR 20Y	N/A

PE Ratio	1.91
PE Ratio Avg TTM	1.42
PE Ratio Avg 3Y	1.42
Current VS TTM Avg	+34.67%
Current VS 3Y Avg	+34.67%
Current VS 5Y Avg	+34.67%

All Metrics

ALDX Valuation Metrics

ALDX Stock Price Metrics

ALDX Dividend Metrics

ALDX Growth Rate Metrics

ALDX Discounted Cash Flow Metrics

ALDX Returns By Period

ALDX Yearly Returns

ALDX Average Annual Returns By Period (CAGR)

ALDX Revenue Metrics

ALDX PE Ratio Metrics

ALDX PS Ratio Metrics

ALDX PB Ratio Metrics

ALDX Price to Free Cash Flow Ratio Metrics

ALDX Debt to Equity Ratio Metrics

ALDX PEG Ratio Metrics

ALDX FCF Yield

ALDX Earnings Yield

ALDX EBITDA Yield

ALDX OCF Yield

ALDX EV/EBIT Ratio Metrics

ALDX EV/EBITDA Ratio Metrics

ALDX EV/Assets Ratio Metrics

ALDX EV/Sales Ratio Metrics

ALDX Current Ratio Metrics

ALDX Quick Ratio Metrics

ALDX ROIC Metrics

ALDX Return on Assets Metrics

ALDX Return on Equity Metrics

ALDX Net Profit Margin Metrics

ALDX Gross Profit Margin Metrics

ALDX Tax Rate Metrics

PS Ratio	25.26
PS Ratio Avg TTM	0.00
PS Ratio Avg 3Y	2.34
Current VS TTM Avg	N/A
Current VS 3Y Avg	+978.30%
Current VS 5Y Avg	+978.30%

PB Ratio	1.47
PB Ratio Avg TTM	4.03
PB Ratio Avg 3Y	3.30
Current VS TTM Avg	-63.52%
Current VS 3Y Avg	-55.45%
Current VS 5Y Avg	-44.72%

PFCF Ratio	N/A
PFCF Ratio Avg TTM	N/A
PFCF Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Debt/Equity Ratio	0.00
Debt/Equity Ratio Avg TTM	0.26
Debt/Equity Ratio Avg 3Y	0.20
Current VS TTM Avg	-98.57%
Current VS 3Y Avg	-98.14%
Current VS 5Y Avg	-97.63%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	N/A
FCF Yield Avg TTM	N/A
FCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Earnings Yield	52.39%
Earnings Yield Avg TTM	64.30%
Earnings Yield Avg 3Y	64.30%
Current VS TTM Avg	-18.52%
Current VS 3Y Avg	-18.52%
Current VS 5Y Avg	-18.52%

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	N/A
Ev/Ebit Ratio Avg TTM	N/A
Ev/Ebit Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebitda Ratio	N/A
Ev/Ebitda Ratio Avg TTM	N/A
Ev/Ebitda Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Assets Ratio	0.23
Ev/Assets Ratio Avg TTM	1.93
Ev/Assets Ratio Avg 3Y	1.74
Current VS TTM Avg	-88.06%
Current VS 3Y Avg	-86.77%
Current VS 5Y Avg	-85.28%

Ev/Sales Ratio	19.55
Ev/Sales Ratio Avg TTM	0.00
Ev/Sales Ratio Avg 3Y	1.80
Current VS TTM Avg	N/A
Current VS 3Y Avg	+989.01%
Current VS 5Y Avg	+989.01%

Current Ratio	4.91
Current Ratio Avg TTM	3.16
Current Ratio Avg 3Y	5.32
Current VS TTM Avg	+55.33%
Current VS 3Y Avg	-7.75%
Current VS 5Y Avg	-40.75%

Quick Ratio	4.91
Quick Ratio Avg TTM	3.16
Quick Ratio Avg 3Y	5.32
Current VS TTM Avg	+55.33%
Current VS 3Y Avg	-7.75%
Current VS 5Y Avg	-40.75%

ROIC	(63.52%)
ROIC Avg 3Y	(52.56%)
ROIC Avg 5Y	(44.19%)
Current VS 3Y Avg	-20.86%
Current VS 5Y Avg	-43.74%
Current VS 10Y Avg	-12.78%

ROA	(48.49%)
ROA Avg TTM	(9.40%)
ROA Avg 3Y	(9.18%)
Current VS TTM Avg	-415.82%
Current VS 3Y Avg	-428.50%
Current VS 5Y Avg	-469.82%

ROE	(60.85%)
ROE Avg TTM	(76.31%)
ROE Avg 3Y	(59.78%)
Current VS TTM Avg	+20.26%
Current VS 3Y Avg	-1.80%
Current VS 5Y Avg	-22.18%

Net Profit Margin	0.00%
Net Profit Margin Avg TTM	0.00%
Net Profit Margin Avg 3Y	0.00%
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Gross Profit Margin	0.00%
Gross Pft Margin Avg TTM	0.00%
Gross Pft Margin Avg 3Y	0.00%
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Tax Rate	0.00%
Tax Rate Avg 3Y	0.00%
Tax Rate Avg 5Y	0.00%
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A
Current VS 10Y Avg	N/A